Lymphoid elements and apoptosis-related proteins (Fas, Fas ligand, p53 and bcl-2) in lichen sclerosus and carcinoma of the vulva

European Journal of Gynaecological Oncology

Volumn 22, Issue 2, 2001, Pages 104-109

  Ben Hur, H ^a   Ashkenazi, M ^a   Huszar, M ^a   Gurevich, P ^a   Zusman, I ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Apoptosis; Carcinoma of vulva; Lichen sclerosus; Proliferation; T and B cells

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KILLER CELL; LICHEN SCLEROSUS ET ATROPHICUS; LYMPHOID TISSUE; MACROPHAGE; MALIGNANT TRANSFORMATION; MORPHOMETRICS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR BIOPSY; VULVA CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; LYMPHOCYTE SUBSETS; MEMBRANE GLYCOPROTEINS; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VULVAR NEOPLASMS;

EID: 0034788054     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Vulvar lichen sclerosus and squamous cell carcinoma: A cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia
2. Pathobiology of vulvar squamous neoplasia
3. An infective aetiology for vulval lichen sclerosus re-addressed
4. Squamous cell carcinoma of the vulva in association with mixed vulvar dystrophy. A brief report with review of literature
5. Current etiopathogenetic views in vulvar cancer
6. Does lichen sclerosis play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis
7. The underreporting of skin disease in association with squamous cell carcinoma of the vulva
8. Vulvar dystrophy: An evaluation of 285 cases
9. Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study
10. p53 overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter
11. Absence of p53 protein overexpression in precancerous lesions of the vulva
12. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change
13. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
14. Squamous cell carcinoma of the vulva: Study of ploidy, HPV, p53, and pRb
15. p53 protein expression in squamous cell carcinoma of the vulva
16. p53 antibody response in patients with vulvar cancer
17. The basement membrane zone in lichen sclerosus: An immunohistochemical study
18. Immunohistochemical staining for proliferating cell nuclear antigen, bcl-2 and Ki-67 in vulvar tissues
19. Vulvar lichen sclerosus: An immunologic study
20. Lichen sclerosus: Early diagnosis is the key to treatment
21. Vulvar intraepithelial neoplasia III: Occult cancer and the impact of margin status on recurrence
22. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: Correlation with prominent fibromyxoid stromal response